Matrix metalloproteinase 9 mRNA: An early prognostic marker for patients with acute stroke

Clinical Biochemistry

Volumn 45, Issue 4-5, 2012, Pages 352-355

  Graham, Colin A ^a   Chan, Rebecca W Y ^a   Chan, Dexter Y S ^b   Chan, Cangel P Y ^a   Wong, Lawrence K S ^a   Rainer, Timothy H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Blood brain barrier; Matrix metalloproteinase 9 (MMP9); Messenger RNA (mRNA); Prognostic; Stroke

Indexed keywords

GELATINASE B; MESSENGER RNA;

ACUTE STROKE; ADULT; AGED; ARTICLE; DISEASE MARKER; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POST STROKE MODIFIED RANKIN SCORE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROKE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD BUFFY COAT; BRAIN ISCHEMIA; EARLY DIAGNOSIS; FEMALE; HEMORRHAGIC DISORDERS; HONG KONG; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84857649421     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.12.006     Document Type: Article

References (10)

1. Chamorro A., Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006, 37:291-293.
2. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 2006, 184:53-68.
3. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., et al. Leukocyte-derived matrix-metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005, 289:558-568.
4. Tang Y., Xu H., Du X., Lit L., Walker W., Lu A., et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006, 26:1089-1102.
5. Abilleira S., Montaner J., Molina C.A., Monasterio J., Castillo J., Alvarez-Sabín J. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003, 99:65-70.
6. Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular diseases III. Stroke 1990, 21:637-676.
7. Chan R.W., Graham C.A., Rainer T.H., Lam N.Y., Chiu R.W., Chik K.W., et al. Use of a bone marrow transplantation model system to demonstrate the hematopoietic origin of plasma S100B mRNA. Clin Chem 2007, 53(10):1874-1876.
8. Brouns R., Wauters A., De Surgeloose D., Mariën P., De Deyn P.P. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol 2011, 65(1):23-31.
9. Castellanos M., Leira R., Serena J., Pumar J.M., Lizasoain I., Castillo J., et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003, 34(1):40-46.
10. Hamann G.F., Okada Y., del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 1996, 16(6):1373-1378.